Mumbai, February 10, 2025 – Godavari Biorefineries Ltd. (NSE: GODAVARIB, BSE: 544279), a leading producer of ethanol and bio-based chemicals, announced its unaudited financial results for Q3 FY25, reporting a 12% YoY increase in revenue, despite pricing pressures in the sugar segment.
Key Financial Highlights (Consolidated)
Particulars (₹ Cr) | Q3 FY25 | Q3 FY24 | 9M FY25 | 9M FY24 |
---|---|---|---|---|
Revenue from Operations | 447.3 | 398.0 | 1,290.7 | 1,071.5 |
EBITDA | 39.7 | 46.8 | (1.4) | 23.6 |
EBITDA Margin (%) | 8.9% | 11.8% | -0.1% | 2.2% |
PAT (excl. one-time impact of Deferred Tax) | 5.8 | 38.4 | (70.8) | (52.9) |
One-time impact of Deferred Tax | 0.0 | 0.0 | 24.5 | 0.0 |
PAT (incl. one-time impact of Deferred Tax) | 5.8 | 38.4 | (95.3) | (52.9) |
PAT Margin (%) | 1.3% | 9.7% | -5.5% | -4.9% |
Note: EBITDA includes other income. Ethanol category includes different grades of alcohol.
Segment-Wise Performance
Sales Volume PerformanceSegment | Q3 FY25 | Q3 FY24 | YoY Growth | 9M FY25 | 9M FY24 | Growth (%) |
---|---|---|---|---|---|---|
Sugar (in Qtl) | 3,42,650 | 2,05,510 | +67% | 12,74,600 | 6,66,286 | +91% |
Bio-Based Chemicals (MT) | 13,617 | 11,101 | +23% | 39,198 | 32,834 | +19% |
Ethanol (KL) | 25,171 | 22,600 | +11% | 49,871 | 57,214 | -13% |
Management Commentary
Shri Samir Somaiya, CMD, stated:"We are continuing to diversify our revenue streams, focusing on bio-based chemicals and strengthening our ethanol division by exploring multiple feedstocks. The bio-chemicals and ethanol segment will be a key driver of our future expansion, reinforcing our vision of building a sustainable, innovation-led bio-refining business."
Additionally, he noted that the Government's recent approval of a 1-million-ton sugar export quota is expected to support pricing and improve industry sentiment."We have expanded our capacity for 1,3 Butylene Glycol, licensed a technology for Bio-Butanol and higher alcohols, placed an order for a corn/grain-based distillery, and used IPO proceeds to reduce term debt, which will lower financing costs going forward."
Strategic Outlook
- Expansion in bio-based chemicals and ethanol to drive growth.
- New technology licensing for bio-butanol production to enhance product portfolio.
- Debt reduction using IPO proceeds to optimize financial performance.
- Improved sugar export policies expected to stabilize prices in upcoming quarters.